SESSION 4.
Artificial Intelligence and its potential role(s) in user innovation.
Professor Pedro Oliveira, Dean of NOVA SBE
Tiago Godinho
Artificial Intelligence (AI) holds tremendous potential in shaping user innovation across various domains. As we delve into the possibilities of AI, its role becomes increasingly evident in empowering users to drive innovation. By harnessing AI technologies, individuals can access intelligent tools that enhance their problem-solving capabilities, boost creativity, and streamline processes. Whether it's through AI-driven data analysis, personalized recommendations, or predictive modeling, users can leverage these advancements to uncover novel solutions and novel ways to address complex challenges. As AI continues to evolve, its symbiotic relationship with user innovation will undoubtedly pave the way for unprecedented advancements and transformative experiences in diverse fields, revolutionizing the way we interact, learn, and innovate
SESSION 5.
Medical liability and standard of care in medical Artificial Intelligence
Helena Canhão, Dean of NOVA MS
Vera Lúcia Raposo. Professor, Nova Law School
Clinicians and patients have the right to explore new and innovative ideas and approaches to healthcare. Innovation is important for improving patient outcomes and the delivery of healthcare. Clinicians can develop new treatments and therapies, and share their innovations with other healthcare professionals to promote new ideas. Patients can explore new treatments and participate in research studies to help develop new therapies. However, innovation must be balanced with patient safety and ethical considerations, and innovations should be rigorously tested and evaluated to ensure they are safe, effective, and meet ethical standards. Overall, healthcare innovation has the potential to improve patient care, but it must be done responsibly and with patient safety in mind.
Reading:
Torrance,AndrewandEricvonHippel(2015)“Therighttoinnovate.”MichiganStateLawReview2015:793 pp. 793 - 829.
SESSION 6.
Adapting medical education and practice to improve adoption of valuable clinician and patient innovations into medical practice in Portugal.
Pedro Oliveira, Dean of NOVA SBE
Helena Canhão, Dean of NOVA MS
Practical examples from MD:
Fátima Serrano | Pedro Flores | Clara Capucho | Ana Rita Jesus
This session focuses on discussing ways to adapt medical education and practice to encourage the adoption of valuable clinician and patient innovations in healthcare. Additionally, the session will explore how these ideas can be implemented in the medical practice in Portugal. The aim would be to find ways to improve patient outcomes and enhance the quality of healthcare delivery in Portugal by promoting the adoption of innovative practices.
Medical education is based on evidence and must-proven activities and interventions. Patient safety is fundamental in every step. Often innovations are difficult to spread due to barriers, misinterpretation, and lack of information. Education related to health must be improved to clarify the benefits of integrating clinician and patient innovations into medical practice.
Implementing diffusion strategies in Portugal's medical practice may require a collaborative effort between medical education institutions, healthcare organizations, and government agencies. By working together, they can promote a culture of innovation and continuous learning that improves patient outcomes and enhances the quality of healthcare delivery in Portugal.
Reading:
Oliveira, Pedro, Leid Zejnilovic, Helena Canhão, and Eric von Hippel (2015) “Innovation by patients with rare diseases and chronic needs. Orphanet Journal of Rare Diseases, 10(1) :41
